CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future
Hyojin Kim, Jin-Haeng Chung
JPTM. 2019;53(4):199-206.   Published online 2019 May 2    DOI: https://doi.org/10.4132/jptm.2019.04.24

Excel Download

The clinical utility of PD-L1 testing in selecting non-small cell lung cancer patients for PD1/PD-L1-directed therapy
Clinical Pharmacology & Therapeutics. 2016;100(3):212-214   Crossref logo
Link1 Link2

PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future
Journal of Pathology and Translational Medicine. 2019;53(4):199-206   Crossref logo
Link1 Link2 Link3

What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?
Lung Cancer. 2019;132:152-153   Crossref logo
Link1 Link2

Are endobronchial ultrasound-guided transbronchial needle aspiration samples adequate for PD-L1 testing in non-small cell lung cancer?
Lung Cancer. 2019;127:S18   Crossref logo
Link1 Link2

Combined modality therapy for non-small cell lung cancer, past, present, and future
Lung Cancer. 2003;42:S35-S40   Crossref logo
Link1 Link2

Past, present, and future of gemcitabine and carboplatin regimens in advanced non-small cell lung cancer
Lung Cancer. 2002;38:37-43   Crossref logo
Link1 Link2

Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non–small cell lung cancer
Lung Cancer. 2016;99:79-87   Crossref logo
Link1 Link2

Concurrent chemoradiation for stage III non small cell lung cancer: Present results and future prospects
Lung Cancer. 1995;13(2):230   Crossref logo
Link1 Link2

First-line pembrolizumab in PD-L1 positive non-small-cell lung cancer: A cost-effectiveness analysis from the UK health care perspective
Lung Cancer. 2018;123:166-171   Crossref logo
Link1 Link2

Clinical presentation and prognosis of high PD-L1 expressors in non-small cell lung cancer
Lung Cancer. 2019;127:S66   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.